These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23642722)

  • 1. Chronic inflammatory demyelinating polyneuropathy.
    Gorson KC; Katz J
    Neurol Clin; 2013 May; 31(2):511-32. PubMed ID: 23642722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
    Mohamed AR; Rodriguez-Casero MV; Ryan MM
    Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
    Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
    Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyneuropathy.
    Köller H; Kieseier BC; Jander S; Hartung HP
    N Engl J Med; 2005 Mar; 352(13):1343-56. PubMed ID: 15800230
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
    Peltier AC; Donofrio PD
    Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
    Kaplan A; Brannagan TH
    Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.
    Stino AM; Naddaf E; Dyck PJ; Dyck PJB
    Muscle Nerve; 2021 Feb; 63(2):157-169. PubMed ID: 32914902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
    Kazmi MA; Mahdi-Rogers M; Sanvito L
    Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.
    Saperstein DS; Barohn RJ
    Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
    Fukushima K; Ikeda SI
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():414-8. PubMed ID: 26480734
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic inflammatory demyelinating polyneuropathy].
    Köller H; Kieseier BC; Jander S; Hartung HP
    Nervenarzt; 2003 Apr; 74(4):320-33. PubMed ID: 12707701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series.
    McMillan HJ; Kang PB; Jones HR; Darras BT
    Neuromuscul Disord; 2013 Feb; 23(2):103-11. PubMed ID: 23140945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
    Ryan M; Ryan SJ
    Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
    Ducray F; Costedoat-Chalumeau N; Bouhour F; Rousset H; Vial C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S85-9. PubMed ID: 18087235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary.
    Oaklander AL; Gimigliano F
    NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.